The pathogenesis of CRC is complicated, which is attributed to the dysregulation of multiple signaling pathways like Wnt, TGFβ and Ras 2-6 , as well as microRNAs 7, making it difficult to develop effective targeted drugs for CRC treatment. This evidence concerns the gene TGFB1 and colorectal carcinoma.